ArticleBMC cancer2023

Claudin18.2 as a potential therapeutic target for primary ovarian mucinous carcinomas and metastatic ovarian mucinous carcinomas from upper gastrointestinal primary tumours.

Fujun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.